What is Algoriom?
Founded in 2018, Algoriom operates at the intersection of data science and advanced analytics. The company's core expertise lies in developing sophisticated predictive models and forecasting tools tailored for sectors including finance, governance, and healthcare. By leveraging cutting-edge algorithms, Algoriom aims to provide actionable insights that drive informed decision-making and optimize outcomes for its clients. Its specialization in drug development analysis within healthcare highlights a commitment to addressing complex challenges in the life sciences.
How much funding has Algoriom raised?
Algoriom has raised a total of $887K across 1 funding round:
Debt
$887K
Debt (2021): $887K with participation from PPP
Key Investors in Algoriom
PPP
Public-Private Partnership
What's next for Algoriom?
With a substantial total funding of $887K and a recent major strategic investment, Algoriom is poised for accelerated growth and innovation. The company is likely to focus on expanding its market reach, further developing its proprietary AI platforms, and forging new partnerships. This strategic backing suggests a strong market validation and provides Algoriom with the resources to enhance its predictive analytics and forecasting solutions, potentially leading to new product launches and deeper penetration into its target industries. The enterprise-level nature of its funding indicates a trajectory towards significant scaling and market leadership.
See full Algoriom company page
